Clinical Trial

Pencil Beam Proton Therapy for Pelvic Recurrences in Rectal Cancer Patients Previously Treated With Radiotherapy

Study acronym: ReRad II
Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated January 5, 2021 (before its estimated October 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Study design: A prospective phase II, non-randomized observational study of dose-escalated pencil beam proton therapy re-irradiation for pelvic recurrences from rectal cancer. Re-irradiation is either a part of neo-adjuvant treatment or as a definitive treatment strategy for un-resectable recurrences.
Trial Details
NCT Number NCT04695782
Lead Sponsor University of Aarhus
Conditions Rectal Cancer Recurrent
Enrollment 65 participants
Start Date 2020-10-10
Primary Completion 2025-10-31 (estimated)
Study Completion 2028-10-31 (estimated)
Updated on ClinicalTrials.gov 2021-01-05